NOF (4403) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
21 May, 2026Executive summary
Achieved record highs in net sales, operating profit, ordinary profit, and net profit for FY2025, with a dividend per share of ¥61, up ¥16 year-over-year.
Net sales rose 8.2% year-over-year to ¥257,967 million, with operating profit up 4.6% and profit attributable to owners of parent up 11.1%.
Growth was driven by business expansion in prioritized fields and cost reduction efforts, despite global economic uncertainties and high raw material prices.
FY2026 forecast targets further record highs in net sales, operating profit, and ordinary profit, factoring in geopolitical risks in the Middle East.
Financial highlights
FY2025 net sales: ¥2,580 billion (+¥197 billion YoY); operating profit: ¥474 billion (+¥21 billion YoY); ordinary profit: ¥504 billion (+¥38 billion YoY); net profit: ¥406 billion (+¥41 billion YoY).
Basic EPS for FY2025: ¥176.3 (+¥22.5 YoY); dividend per share: ¥61 (+¥16 YoY).
FY2026 forecast: net sales ¥3,190 billion (+23.7% YoY), operating profit ¥500 billion (+5.5% YoY), ordinary profit ¥510 billion (+1.3% YoY), net profit ¥390 billion (-3.8% YoY), EPS ¥169.6.
Total assets: ¥399,168 million; Net assets: ¥296,465 million; Equity-to-asset ratio: 74.0%.
Annual dividend: ¥61 per share; payout ratio: 34.6%.
Outlook and guidance
FY2026 guidance incorporates higher raw material and fuel costs, supply chain impacts, and continued geopolitical tensions.
Exchange rate assumptions: JPY/USD 150, JPY/EUR 180.
ROE forecast for FY2026 is 13.1%, with a new target of 14%+ by 2028 and 15%+ by 2030.
FY2027 forecast: Net sales ¥319,000 million (+23.7% YoY), operating profit ¥50,000 million (+5.5%), ordinary profit ¥51,000 million (+1.3%), profit attributable to owners of parent ¥39,000 million (−3.8%), EPS ¥169.60.
Annual dividend forecast for FY2027: ¥70 per share.
Latest events from NOF
- Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 202613 Feb 2026 - Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 202618 Nov 2025 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 20255 Jun 2025